Regulatory News
Wednesday, September 21, 2016
BRIEF-Epizyme collaborates with Foundation Medicine for tazemetostat phase 2 clinical trial
* Epizyme establishes collaboration with Foundation Medicine
to support tazemetostat phase 2 clinical trial
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment